Ethics in Data-driven Research: WMA Declaration of Taipei on Health Databases and Biobanks Part 3: Opinions from Patients and the Public

The WMA’s Declaration of Taipei (DoT), now in the revision process, is important for patients and the public as it is related to the use of a large number of data, including development and use of Artificial Intelligence (AI). This webinar is co-ordinated by IFAPP’s Japanese NMA, JAPhMed, collaborating with a patient group.

Free IFAPP Webinar 2026.

Shinichi Nishiuma, MD. Vice president and Chair of Medical Affairs Committee, Japanese Association of Pharmaceutical Medicine (JAPhMed), Founder and CEO, Nishiuma Co., Ltd.

Atsushi Kuga, MD, PhD. Head of Clinical Development Committee, JAPhMed, Medical Director, Plasma Derived Therapy Unit, Takeda Development Center Japan

Chieko Kurihara, JAPhMed/IFAPP/Ji4pe organises and introduces this webinar. See WMA DoT: https://www.wma.net/policies-post/wma-declaration-of-taipei-on-ethical-considerations-regarding-health-databases-and-biobanks/